• 以固定汇率CER 1 计算，2026年初至今的总销售额增长24.6%，以报告汇率计算增长23.0%，核心产品组合 2 销售额增长24.2% ...

Ipsen delivered strong performance in the third quarter of 2026, with total sales growth of 24.6% at constant exchange rates, driven by continued momentum across Oncology, Rare Disease and ...

Ipsen a enregistré une solide performance au troisième trimestre 2026, avec une croissance de son chiffre d’affaires de 24,6 % à taux de change constants, portée par une dynamique soutenue dans ses ...

Croissance du chiffre d’affaires du Groupe de 24,6 % à taux de change constant1 (TCC) au cours des neuf premiers mois de l’année 2026 ou 23,0 % en données publiées, avec une croissance du portefeuille ...

“Our outstanding performance in the first nine months of 2026 is driven by the strength of our core portfolio and continued growth of Somatuline. This momentum, combined with disciplined execution, ...

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia. Detailed Description: This is a Phase 3, multi-center, open-label ...

This study aims to find the right dosage and evaluate the safety and effectiveness of the drug IPN60300 in adults with advanced solid tumours, which are cancers that have spread to other parts of the ...

Fibrodysplasia Ossificans Progressiva (FOP) is a rare, severely disabling disease characterized by heterotopic ossification (HO) often associated with painful, recurrent episodes of soft tissue ...

The purpose of this study is to assess the efficacy and safety of multiple doses of Dysport used in the treatment of upper limb spasticity (altered skeletal muscle performance) in children with ...

The overall objective of this study is to evaluate the efficacy and safety of cabozantinib as 2nd line treatment in subjects with unresectable, locally advanced or metastatic RCC with a clear-cell ...

The purpose of this extension study is to assess the long term safety of patients with neuroendocrine tumour, who are treated with lanreotide Autogel and who participated in a previous study, ...

The purpose of the study is to assess the efficacy of an extended injection interval schedule of lanreotide Autogel 120 mg in acromegalic subjects who are ...